Family-Based HIV and Sexually Transmitted Infection Risk Reduction for Drug-Involved Young Offenders: 42-Month Outcomes

Cynthia L Rowe, Linda Alberga, Gayle A Dakof, Craig E. Henderson, Rocio Ungaro, Howard A Liddle

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This study tested a family-based human immunodeficiency virus (HIV)/sexually transmitted infection (STI) prevention approach integrated within an empirically supported treatment for drug-involved young offenders, Multidimensional Family Therapy (MDFT). A randomized, controlled, two-site community-based trial was conducted with 154 youth and their parents. Drug-involved adolescents were recruited in detention, randomly assigned to either MDFT or Enhanced Services as Usual (ESAU), and assessed at intake, 3, 6, 9, 18, 24, 36, and 42-month follow-ups. Youth in both conditions received structured HIV/STI prevention in detention and those in MDFT also received family-based HIV/STI prevention as part of ongoing treatment following detention release. Youth in both conditions and sites significantly reduced rates of unprotected sex acts and STI incidence from intake to 9 months. They remained below baseline levels of STI incidence (10%) over the 42-month follow-up period. At Site A, adolescents who were sexually active at intake and received MDFT showed greater reduction in overall frequency of sexual acts and number of unprotected sexual acts than youth in ESAU between intake and 9-month follow-ups. These intervention differences were evident through the 42-month follow-up. Intervention effects were not found for STI incidence or unprotected sex acts at Site B. Intensive group-based and family intervention in detention and following release may reduce sexual risk among substance-involved young offenders, and a family-based approach may enhance effects among those at highest risk. Site differences in intervention effects, study limitations, clinical implications, and future research directions are discussed.

Original languageEnglish (US)
Pages (from-to)305-320
Number of pages16
JournalFamily Process
Volume55
Issue number2
DOIs
StatePublished - Jun 1 2016

Fingerprint

Risk Reduction Behavior
Sexually Transmitted Diseases
family therapy
offender
Family Therapy
HIV
drug
incidence
Pharmaceutical Preparations
Unsafe Sex
adolescent
Incidence
parents
Parents
community
Group
Therapeutics

Keywords

  • Adolescents
  • Detention
  • Families
  • Human Immunodeficiency Virus
  • Intervention
  • Juvenile Justice
  • Sexually Transmitted Infection

ASJC Scopus subject areas

  • Social Psychology
  • Clinical Psychology
  • Social Sciences (miscellaneous)

Cite this

Family-Based HIV and Sexually Transmitted Infection Risk Reduction for Drug-Involved Young Offenders : 42-Month Outcomes. / Rowe, Cynthia L; Alberga, Linda; Dakof, Gayle A; Henderson, Craig E.; Ungaro, Rocio; Liddle, Howard A.

In: Family Process, Vol. 55, No. 2, 01.06.2016, p. 305-320.

Research output: Contribution to journalArticle

Rowe, Cynthia L ; Alberga, Linda ; Dakof, Gayle A ; Henderson, Craig E. ; Ungaro, Rocio ; Liddle, Howard A. / Family-Based HIV and Sexually Transmitted Infection Risk Reduction for Drug-Involved Young Offenders : 42-Month Outcomes. In: Family Process. 2016 ; Vol. 55, No. 2. pp. 305-320.
@article{1f3ed245edcb4195afe395431a24f000,
title = "Family-Based HIV and Sexually Transmitted Infection Risk Reduction for Drug-Involved Young Offenders: 42-Month Outcomes",
abstract = "This study tested a family-based human immunodeficiency virus (HIV)/sexually transmitted infection (STI) prevention approach integrated within an empirically supported treatment for drug-involved young offenders, Multidimensional Family Therapy (MDFT). A randomized, controlled, two-site community-based trial was conducted with 154 youth and their parents. Drug-involved adolescents were recruited in detention, randomly assigned to either MDFT or Enhanced Services as Usual (ESAU), and assessed at intake, 3, 6, 9, 18, 24, 36, and 42-month follow-ups. Youth in both conditions received structured HIV/STI prevention in detention and those in MDFT also received family-based HIV/STI prevention as part of ongoing treatment following detention release. Youth in both conditions and sites significantly reduced rates of unprotected sex acts and STI incidence from intake to 9 months. They remained below baseline levels of STI incidence (10{\%}) over the 42-month follow-up period. At Site A, adolescents who were sexually active at intake and received MDFT showed greater reduction in overall frequency of sexual acts and number of unprotected sexual acts than youth in ESAU between intake and 9-month follow-ups. These intervention differences were evident through the 42-month follow-up. Intervention effects were not found for STI incidence or unprotected sex acts at Site B. Intensive group-based and family intervention in detention and following release may reduce sexual risk among substance-involved young offenders, and a family-based approach may enhance effects among those at highest risk. Site differences in intervention effects, study limitations, clinical implications, and future research directions are discussed.",
keywords = "Adolescents, Detention, Families, Human Immunodeficiency Virus, Intervention, Juvenile Justice, Sexually Transmitted Infection",
author = "Rowe, {Cynthia L} and Linda Alberga and Dakof, {Gayle A} and Henderson, {Craig E.} and Rocio Ungaro and Liddle, {Howard A}",
year = "2016",
month = "6",
day = "1",
doi = "10.1111/famp.12206",
language = "English (US)",
volume = "55",
pages = "305--320",
journal = "Family Process",
issn = "0014-7370",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Family-Based HIV and Sexually Transmitted Infection Risk Reduction for Drug-Involved Young Offenders

T2 - 42-Month Outcomes

AU - Rowe, Cynthia L

AU - Alberga, Linda

AU - Dakof, Gayle A

AU - Henderson, Craig E.

AU - Ungaro, Rocio

AU - Liddle, Howard A

PY - 2016/6/1

Y1 - 2016/6/1

N2 - This study tested a family-based human immunodeficiency virus (HIV)/sexually transmitted infection (STI) prevention approach integrated within an empirically supported treatment for drug-involved young offenders, Multidimensional Family Therapy (MDFT). A randomized, controlled, two-site community-based trial was conducted with 154 youth and their parents. Drug-involved adolescents were recruited in detention, randomly assigned to either MDFT or Enhanced Services as Usual (ESAU), and assessed at intake, 3, 6, 9, 18, 24, 36, and 42-month follow-ups. Youth in both conditions received structured HIV/STI prevention in detention and those in MDFT also received family-based HIV/STI prevention as part of ongoing treatment following detention release. Youth in both conditions and sites significantly reduced rates of unprotected sex acts and STI incidence from intake to 9 months. They remained below baseline levels of STI incidence (10%) over the 42-month follow-up period. At Site A, adolescents who were sexually active at intake and received MDFT showed greater reduction in overall frequency of sexual acts and number of unprotected sexual acts than youth in ESAU between intake and 9-month follow-ups. These intervention differences were evident through the 42-month follow-up. Intervention effects were not found for STI incidence or unprotected sex acts at Site B. Intensive group-based and family intervention in detention and following release may reduce sexual risk among substance-involved young offenders, and a family-based approach may enhance effects among those at highest risk. Site differences in intervention effects, study limitations, clinical implications, and future research directions are discussed.

AB - This study tested a family-based human immunodeficiency virus (HIV)/sexually transmitted infection (STI) prevention approach integrated within an empirically supported treatment for drug-involved young offenders, Multidimensional Family Therapy (MDFT). A randomized, controlled, two-site community-based trial was conducted with 154 youth and their parents. Drug-involved adolescents were recruited in detention, randomly assigned to either MDFT or Enhanced Services as Usual (ESAU), and assessed at intake, 3, 6, 9, 18, 24, 36, and 42-month follow-ups. Youth in both conditions received structured HIV/STI prevention in detention and those in MDFT also received family-based HIV/STI prevention as part of ongoing treatment following detention release. Youth in both conditions and sites significantly reduced rates of unprotected sex acts and STI incidence from intake to 9 months. They remained below baseline levels of STI incidence (10%) over the 42-month follow-up period. At Site A, adolescents who were sexually active at intake and received MDFT showed greater reduction in overall frequency of sexual acts and number of unprotected sexual acts than youth in ESAU between intake and 9-month follow-ups. These intervention differences were evident through the 42-month follow-up. Intervention effects were not found for STI incidence or unprotected sex acts at Site B. Intensive group-based and family intervention in detention and following release may reduce sexual risk among substance-involved young offenders, and a family-based approach may enhance effects among those at highest risk. Site differences in intervention effects, study limitations, clinical implications, and future research directions are discussed.

KW - Adolescents

KW - Detention

KW - Families

KW - Human Immunodeficiency Virus

KW - Intervention

KW - Juvenile Justice

KW - Sexually Transmitted Infection

UR - http://www.scopus.com/inward/record.url?scp=85027921167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027921167&partnerID=8YFLogxK

U2 - 10.1111/famp.12206

DO - 10.1111/famp.12206

M3 - Article

C2 - 26879671

AN - SCOPUS:85027921167

VL - 55

SP - 305

EP - 320

JO - Family Process

JF - Family Process

SN - 0014-7370

IS - 2

ER -